Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients

被引：2
|
作者：
Patoulias, Dimitrios [1 ]
Papadopoulos, Christodoulos [2 ]
Stavropoulos, Konstantinos [1 ]
Imprialos, Konstantinos [1 ]
Doumas, Michael [1 ,3 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Dept Cardiol 3, Thessaloniki, Greece
[3] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2020年 / 137卷
关键词：
OUTCOMES; HEALTH;
D O I：
10.1016/j.amjcard.2020.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 135
页数：3
相关论文
共 50 条
  • [1] UPDATED META-ANALYSIS OF TRIALS ASSESSING THE CARDIOVASCULAR EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN BLACK PATIENTS
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Katsimardou, Alexandra
    Toumpourleka, Maria
    Mavridou, Maria
    Papadopoulos, Christodoulos
    Doumas, Michael
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 : E215 - E216
  • [2] Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis
    Hussein, H.
    Zaccardi, F.
    Khunti, K.
    Seidu, S.
    Davies, M. J.
    Gray, L. J.
    [J]. DIABETIC MEDICINE, 2019, 36 (04) : 444 - 452
  • [3] Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis
    Hussein, H.
    Zaccardi, F.
    Khunti, K.
    Seidu, S.
    Davies, M. J.
    Gray, L. J.
    [J]. DIABETIC MEDICINE, 2019, 36 : 80 - 80
  • [4] Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis
    Hussein, Humaira
    Zaccardi, Francesco
    Khunti, Kamlesh
    Davies, Melanie J.
    Patsko, Emily
    Dhalwani, Nafeesa N.
    Kloecker, David E.
    Ioannidou, Ekaterini
    Gray, Laura J.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1035 - 1046
  • [5] Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?
    Goncalves, Edison
    Bell, David S. H.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 909 - 911
  • [6] Cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: The P value and beyond
    Kloecker, David E.
    Davies, Melanie J.
    Khunti, Kamlesh
    Zaccardi, Francesco
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1685 - 1691
  • [7] Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis
    Mantsiou, Chrysanthi
    Karagiannis, Thomas
    Kakotrichi, Panagiota
    Malandris, Konstantinos
    Avgerinos, Ioannis
    Liakos, Aris
    Tsapas, Apostolos
    Bekiari, Eleni
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1857 - 1868
  • [8] The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
    Ueda, Peter
    Wintzell, Viktor
    Dahlqwist, Elisabeth
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Franzen, Stefan
    Gudbjornsdottir, Soffia
    Hveem, Kristian
    Jonasson, Christian
    Melbye, Mads
    Hviid, Anders
    Svanstrom, Henrik
    Pasternak, Bjorn
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (03): : 473 - 485
  • [9] Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes
    Tjerkaski, J.
    Ueda, P.
    Alfredsson, J.
    Erlinge, D.
    Lindahl, B.
    Mohammad, M. A.
    Omerovic, E.
    Reitan, C.
    Svensson, P.
    Jernberg, T.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [10] Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis
    Albulushi, Arif
    Tanoh, Desmond Boakye
    Almustafa, Ahmed
    Al Matrooshi, Nadya
    Zolty, Ronald
    Lowes, Brian
    [J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
12345